<html>
<head>PUBMED IDs for hPEBP4</head>
<body bgcolor='#C5F0F2'><h1>hPEBP4</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16865237/'>Anti-apoptotic hPEBP4 silencing promotes TRAIL-induced apoptosis of human ovarian cancer cells by activating ERK and JNK pathways.</a> July 26  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/20460377/'>Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ERalpha) in human cancer cells by inhibiting proteasome-dependent ERalpha degradation via association with Src.</a> August 7  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/23451095/'>Silencing of human phosphatidylethanolamine-binding protein 4 enhances rituximab-induced death and chemosensitization in B-cell lymphoma.</a> September 4  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24276246/'>Phosphatidylethanolamine-binding protein 4 is associated with breast cancer metastasis through Src-mediated Akt tyrosine phosphorylation.</a> November 11  2013<br></body></html>
